コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nine vasopressin, agouti-related protein and alpha-melanocyte stimulating hormone.
2 detectable levels of adrenocorticotropin or alpha-melanocyte-stimulating hormone.
3 examined how these responses are affected by alpha-melanocyte-stimulating hormone.
4 production but this response was reduced by alpha-melanocyte-stimulating hormone.
5 hat the levels were increased in response to alpha-melanocyte-stimulating hormone.
6 tions on stimulation with its natural ligand alpha-melanocyte-stimulating hormone.
7 abated the positive effects of [Nle, D-Phe]-alpha-melanocyte-stimulating hormone.
8 as glucagon and proopiomelanocortin-derived alpha-melanocyte-stimulating hormone.
10 cy of (188)Re-(Arg(11))[Cys(3,4,10),d-Phe(7)]alpha-melanocyte-stimulating hormone(3-13) (CCMSH) in th
11 ,8 tetrahydrobiopterin resulting in a stable alpha-melanocyte stimulating hormone/6(R)-L-erythro 5,6,
12 ojic acid, and niacinamide) and stimulators (alpha-melanocyte-stimulating hormone, 8-methoxypsoralen,
13 e inhibitor of rac1 abrogated the ability of alpha-melanocyte stimulating hormone, a peptide hormone
15 vity of the melanotropin peptides alpha-MSH (alpha-melanocyte-stimulating hormone, Ac-Ser-Tyr-Met-Glu
16 sion this study provides further evidence of alpha-melanocyte stimulating hormone acting to "protect"
17 on is similar in these two species homologs (alpha-melanocyte-stimulating hormone = adrenocorticotrop
18 For this purpose antibodies against alpha-melanocyte stimulating hormone, adrenocorticotropi
20 effects of two melanocortin system ligands, alpha melanocyte stimulating hormone (alpha-MSH) and ago
21 Within the ARC, IRS-2 was co-localized with alpha melanocyte stimulating hormone (alpha-MSH) as well
22 under both direct and indirect regulation by alpha melanocyte-stimulating hormone (alpha-MSH)-synthes
26 cotropic hormone (ACTH), beta-endorphin, and alpha-melanocyte stimulating hormone (alpha-MSH) are syn
27 Both forms act as competitive antagonists of alpha-melanocyte stimulating hormone (alpha-MSH) at mela
28 etermine whether the neuroprotective peptide alpha-melanocyte stimulating hormone (alpha-MSH) attenua
30 te nucleus (ARC), and on opioid peptides and alpha-melanocyte stimulating hormone (alpha-MSH) in the
31 ne-regulated transcript (CART) coexists with alpha-melanocyte stimulating hormone (alpha-MSH) in the
34 opiomelanocortin (POMC)-derived neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) is know
36 ed and compared with four other radiolabeled alpha-melanocyte stimulating hormone (alpha-MSH) peptide
37 rg-X-Asp-conjugated and X-Ala-Asp-conjugated alpha-melanocyte stimulating hormone (alpha-MSH) peptide
38 of new (99m)Tc-labeled Arg-X-Asp-conjugated alpha-melanocyte stimulating hormone (alpha-MSH) peptide
39 elanoma prevention based on using analogs of alpha-melanocyte stimulating hormone (alpha-MSH) that fu
42 acrophage chemoattractant protein-1 (MCP-1), alpha-melanocyte stimulating hormone (alpha-MSH), and pe
43 -DOTA-ReCCMSH(Arg(11)), a cyclic analogue of alpha-melanocyte stimulating hormone (alpha-MSH), exhibi
44 ng factor (CRF) might be mediated via MC4-R. alpha-Melanocyte stimulating hormone (alpha-MSH), the MC
45 ncreasing the production of the MC4R ligand, alpha-melanocyte stimulating hormone (alpha-MSH), to reg
46 ach, MC4-R agonists, melanotan-II (MT-II) or alpha-melanocyte stimulating hormone (alpha-MSH), were u
50 or cells was blocked by co-administration of alpha-melanocyte stimulating hormone (alpha-MSH, 20 ng),
51 nal activity of leptin, the leptin receptor, alpha-melanocyte stimulating hormones (alpha-MSH) and th
52 whether the functional IL-1beta antagonist, alpha-melanocyte-stimulating hormone (alpha-MSH(1-13)),
53 odistribution, and clearance kinetics of the alpha-melanocyte-stimulating hormone (alpha-MSH) analog
55 We report in vitro and in vivo data of new alpha-melanocyte-stimulating hormone (alpha-MSH) analogu
56 de Y (NPY) and anorexigenic peptides such as alpha-melanocyte-stimulating hormone (alpha-MSH) and ano
57 ression, resulting in selective increases of alpha-melanocyte-stimulating hormone (alpha-Msh) and car
58 G protein-coupled receptor (GPCR) that binds alpha-melanocyte-stimulating hormone (alpha-MSH) and has
61 These proteins antagonize the effects of alpha-melanocyte-stimulating hormone (alpha-MSH) and oth
62 opposing effects of the anorexigenic agonist alpha-melanocyte-stimulating hormone (alpha-MSH) and the
65 food intake and PK2 increased the release of alpha-melanocyte-stimulating hormone (alpha-MSH) from ex
66 -clamp recordings revealed that both NPY and alpha-melanocyte-stimulating hormone (alpha-MSH) inhibit
70 state, the appetite-suppressing neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) is redu
71 in (ACTH) of pars distalis corticotropes and alpha-melanocyte-stimulating hormone (alpha-MSH) of pars
72 This study aimed at revealing the role of alpha-melanocyte-stimulating hormone (alpha-MSH) on baso
73 esize melanocortin receptor agonists such as alpha-melanocyte-stimulating hormone (alpha-MSH) or anta
74 e of the radiolabeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone (alpha-MSH) peptide
75 termine whether (99m)Tc- and (111)In-labeled alpha-melanocyte-stimulating hormone (alpha-MSH) peptide
76 ating phage that displayed up to 5 copies of alpha-melanocyte-stimulating hormone (alpha-MSH) peptide
77 (POMC) neurons and the POMC-derived peptide alpha-melanocyte-stimulating hormone (alpha-MSH) promote
78 cortin type 1 receptor (MC1R), also known as alpha-melanocyte-stimulating hormone (alpha-MSH) recepto
80 mentation (suntanning) requires induction of alpha-melanocyte-stimulating hormone (alpha-MSH) secreti
84 nzyme prolylcarboxypeptidase (PRCP) degrades alpha-melanocyte-stimulating hormone (alpha-MSH) to an i
85 ow coat color by antagonizing the binding of alpha-melanocyte-stimulating hormone (alpha-MSH) to the
86 nucleus of the hypothalamus (PVN), to block alpha-melanocyte-stimulating hormone (alpha-MSH) type 3
87 for MC1R, inhibiting the alpha-melanocortin (alpha-melanocyte-stimulating hormone (alpha-MSH))-induce
88 for melanocortin 4 (MC-4) receptors such as alpha-melanocyte-stimulating hormone (alpha-MSH), a prod
89 volved in the regulation of feeding by using alpha-melanocyte-stimulating hormone (alpha-MSH), an end
90 ',N'''-tetraacetic acid), a cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH), has th
91 amus and regulating release of products like alpha-melanocyte-stimulating hormone (alpha-MSH), neurop
92 NPY) are potent appetite stimulants, whereas alpha-melanocyte-stimulating hormone (alpha-MSH), neurot
93 s of either a melanocortin receptor agonist, alpha-melanocyte-stimulating hormone (alpha-MSH), or ant
94 a-MSH (NDP-MSH), a highly potent analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), posses
95 dy was designed to examine the evidence that alpha-melanocyte-stimulating hormone (alpha-MSH), which
96 -amino group of Lys(10) of the cyclic lactam alpha-melanocyte-stimulating hormone (alpha-MSH)-derived
102 ere blocked by 2 different IL-1 antagonists, alpha melanocyte stimulating hormone (alphaMSH) and inte
105 wever, melanoma cells synthesize and release alpha-melanocyte stimulating hormone (alphaMSH, the liga
106 The behavior of these cells is influenced by alpha-melanocyte-stimulating hormone (alphaMSH) and mela
108 Interestingly, hypothalamic Pomc mRNA and alpha-melanocyte-stimulating hormone (alphaMSH) peptide
110 ibits the rise in cAMP levels in response to alpha-melanocyte-stimulating hormone, an MC4R agonist, b
112 stitutions did not affect the ability of the alpha-melanocyte stimulating hormone analogue [Nle4,D-Ph
113 We evaluated the safety and efficacy of an alpha-melanocyte-stimulating hormone analogue, afamelano
115 nduce dendrite formation in B16F1 cells, and alpha-melanocyte stimulating hormone and ultraviolet lig
116 that rac1 mediates the well-known ability of alpha-melanocyte stimulating hormone and ultraviolet lig
119 in; the proopiomelanocortin-derived peptides alpha-melanocyte-stimulating hormone and beta-endorphin,
121 n or contraction in melanocytes, mediated by alpha-melanocyte-stimulating hormone and melanin-concent
122 alpha, and of the anti-inflammatory peptides alpha-melanocyte-stimulating hormone and melanocyte-stim
123 marrow-derived macrophages, we observed that alpha-melanocyte-stimulating hormone and selective MC1-R
124 s spectra of the model peptides (bradykinin, alpha-melanocyte stimulating hormone, and melittin) chan
125 ro-opiomelanocortin (POMC)-derived peptides, alpha-melanocyte-stimulating hormone, and adrenocorticot
126 f dynorphin A-17, a decrease in the level of alpha-melanocyte-stimulating hormone, and an alteration
127 c gene encodes both the anorexigenic peptide alpha-melanocyte-stimulating hormone, and the opioid pep
128 dy was to investigate the mechanism by which alpha-melanocyte-stimulating hormone antagonizes proinfl
129 vasion and that the anti-invasive actions of alpha-melanocyte stimulating hormone are consistent with
130 tropic hormone, beta-lipotropic hormone, and alpha-melanocyte-stimulating hormone are also derived.
131 ls of stochastic carcinogenesis and identify alpha-melanocyte-stimulating hormone as a potential atte
133 effects through the blockade of signaling by alpha-melanocyte-stimulating hormone at central nervous
136 loudman S-91 mouse melanoma cells respond to alpha-melanocyte-stimulating hormone) by demonstrating a
139 to the cell surface, but it does not restore alpha-melanocyte-stimulating hormone-dependent cAMP sign
140 (99m)Tc(CO)3-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone derivative, betaAla
141 tide that inhibits the binding and action of alpha-melanocyte-stimulating hormone derived from proopi
145 eptides (dynorphin A-17, beta-endorphin, and alpha- melanocyte-stimulating hormone) involved in the c
146 its production by melanocytes in response to alpha-melanocyte-stimulating hormone is associated with
149 d integrin expression and ask to what extent alpha-melanocyte stimulating hormone might protect cells
150 ts of two intercellular signaling molecules, alpha-melanocyte stimulating hormone (MSH) and agouti si
151 or induces activation of regulatory T cells, alpha-melanocyte stimulating hormone (MSH) and transform
152 Pigmentation in mammals is stimulated by alpha-melanocyte stimulating hormone (MSH), which binds
153 on of two intercellular signaling molecules, alpha-melanocyte-stimulating hormone (MSH) and agouti si
154 which may mediate the hypophagic effects of alpha-melanocyte-stimulating hormone (MSH) in the rat.
155 sthetized rats, unilateral microinjection of alpha-melanocyte-stimulating hormone (MSH) into the medu
159 the complete loss of both [Nle(4)-d-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH) binding a
160 cture-activity studies of [Nle(4), D-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH) identifie
161 ic agouti-related protein (AGRP)/[Nle4,DPhe7]alpha-melanocyte stimulating hormone (NDP-MSH) ligands i
162 the protective effect of [Nle(4), D-Phe(7)]-alpha-melanocyte stimulating hormone (NDP-MSH), a potent
164 d using assays for agonist, [Nle(4)-d-Phe(7)]alpha-melanocyte-stimulating hormone (NDP-alpha-MSH) or
165 sm of human MC4R activation by [Nle4, d-Phe7]alpha-melanocyte-stimulating hormone (NDP-MSH), by first
166 ope of neuropeptide glutamic acid-isoleucine/alpha-melanocyte-stimulating hormone (NEI/alphaMSH) pept
168 d been grown in the presence of 10-11-10-9 M alpha-melanocyte-stimulating hormone prior to stimulatio
169 through actions on TRH neurons, addition of alpha-melanocyte-stimulating hormone produced a 3.5-fold
170 ion of the expression of proopiomelanocortin/alpha-melanocyte-stimulating hormone, provoked by C75 an
171 y pathologies concerning cells which express alpha-melanocyte-stimulating hormone receptors and utili
173 s corticotropin-releasing factor, leptin and alpha-melanocyte stimulating hormone regulate cytokine b
175 othalamic explants but significantly reduced alpha melanocyte stimulating hormone release in vitro.
176 temperature just before light onset, whereas alpha-melanocyte stimulating hormone release, especially
177 selectively increases beta-endorphin but not alpha-melanocyte-stimulating hormone release in the hypo
178 or in mediating immunomodulatory actions of alpha-melanocyte-stimulating hormone remains to be seen.
179 rs with the melanocortin analog [Nle, D-Phe]-alpha-melanocyte-stimulating hormone (starting 3 or 6 hr
180 h as endothelin 1, hepatocyte growth factor, alpha-melanocyte stimulating hormone, stem cell factor,
182 preputial glands of rodents is regulated by alpha-melanocyte stimulating hormone, the major agonist
183 ared with the regulation of melanogenesis by alpha-melanocyte-stimulating hormone through melanocorti
184 by Western immunoblotting and the ability of alpha-melanocyte stimulating hormone to oppose the actio
187 ction of NF-kappaB DNA binding activity with alpha-melanocyte-stimulating hormone was detected 2 h af
188 ease in cAMP in response to stimulation with alpha-melanocyte-stimulating hormone was measured in HEK
189 by elevating cyclic adenosine monophosphate, alpha-melanocyte-stimulating hormone was not found to ha
190 or and appear to be physiological targets of alpha-melanocyte-stimulating hormone, which inhibits foo
191 es, and tumorigenicity assays indicates that alpha-melanocyte-stimulating hormone, which is overprodu
192 y, which aims to maintain high urine output; alpha-melanocyte-stimulating hormone, with anti-inflamma
193 edulla and in a subset of cells coexpressing alpha-melanocyte-stimulating hormone within the pituitar
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。